To confirm that, here we performed a JNK or JAK2 inhibitor test by assessing the anti-cancer effects of pKAL on CD44, Oct 3/4, β-catenin, and MMP-9 as well as the STAT 3 activity of RT-R-MDA-MB-231 cells. Here, MMP9 is linked to cancer.